FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

426455008: Sunitinib malate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2007. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2661574016 Sunitinib malate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2675155011 Sunitinib malate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
843271000172114 malate de sunitinib fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sunitinib malate (substance) Is a Sunitinib (substance) false Inferred relationship Some
Sunitinib malate (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Protein-tyrosine kinase inhibitor (disposition) true Inferred relationship Some
Sunitinib malate (substance) Is a Azole false Inferred relationship Some
Sunitinib malate (substance) Is a Protein-tyrosine kinase inhibitor true Inferred relationship Some
Sunitinib malate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Sunitinib (substance) true Inferred relationship Some
Sunitinib malate (substance) Is a Enzyme inhibitor false Inferred relationship Some
Sunitinib malate (substance) Is a Pyrrole true Inferred relationship Some
Sunitinib malate (substance) Is a Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) true Inferred relationship Some
Sunitinib malate (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Angiogenesis inhibitor (disposition) true Inferred relationship Some
Sunitinib malate (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Vascular endothelial growth factor receptor antagonist (disposition) true Inferred relationship Some
Sunitinib malate (substance) Is a Antineoplastic agent (substance) true Inferred relationship Some
Sunitinib malate (substance) Is a Angiogenesis inhibitor true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely sunitinib (as sunitinib malate) 25 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sunitinib malate (substance) Inferred relationship Some
Product containing precisely sunitinib (as sunitinib malate) 12.5 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sunitinib malate (substance) Inferred relationship Some
Sunitinib (as sunitinib malate) 50 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sunitinib malate (substance) Inferred relationship Some
Product containing precisely sunitinib (as sunitinib malate) 25 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sunitinib malate (substance) Inferred relationship Some 1
Product containing precisely sunitinib (as sunitinib malate) 12.5 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sunitinib malate (substance) Inferred relationship Some 1
Sunitinib (as sunitinib malate) 50 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sunitinib malate (substance) Inferred relationship Some 1
Sunitinib (as sunitinib malate) 50 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sunitinib malate (substance) Inferred relationship Some 1
Product containing precisely sunitinib (as sunitinib malate) 12.5 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sunitinib malate (substance) Inferred relationship Some 1
Product containing precisely sunitinib (as sunitinib malate) 25 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sunitinib malate (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start